In our study, we analysed the polymorphisms of the TEP1 gene rs1760904, rs1713418, and the TERC gene rs12696304 and rs35073794 in 200 MS patients and 230 healthy individuals, because the SNPs we selected have not been studied in scientific research on the pathogenesis and development of MS. This evidence concerns the gene TERC and myeloid sarcoma.